CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$1.19−0.12 (-9.16%)
Close on Nov 12, 2026Market cap $20.93MP/E –Yield –
Cel Sci operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2014 it was -9721.4%, against -12450.1% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Sep 30, 2014 | -9721.4% | +2728.7 |
| FY2013 | Sep 30, 2013 | -12450.1% | −5677.9 |
| FY2012 | Sep 30, 2012 | -6772.3% | −4891.2 |
| FY2011 | Sep 30, 2011 | -1881.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -27366.3% | – |
See a number that looks wrong?